RNU6-182P

Across TCGA pan-cancer cohorts, RNU6-182P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RNU6-182P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RNU6-182P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-182P expression acts as an unfavorable survival marker, although some lineages such as BLCA and PRAD show a favorable association.

MESO, THCA, and UCS are the cancer types where RNU6-182P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.036	0.563	<.001	63	view →
THCA	OS	Tertile	All	0.940	0.988	<.001	51	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
ACC	DFS	Tertile	III,IV	0.010	0.364	<.001	36	view →
BLCA	OS	Tertile	All	0.842	0.279	.010	33	view →
LIHC	DFS	Tertile	All	0.194	0.558	.013	27	view →
KICH	OS	Tertile	All	0.917	1.000	.014	24	view →
PRAD	DFS	Tertile	All	0.966	0.870	.021	18	view →
UCEC	DFS	Tertile	All	0.242	0.667	.002	18	view →
SKCM	OS	Tertile	IV	0.179	0.755	<.001	18	view →
COAD	DFS	Tertile	All	0.515	0.707	.016	12	view →
OV	DFS	Tertile	III,IV	0.124	0.171	.047	2	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RNU6-182P–MESO (OS)

Open the MESO breakdown →